TrialPsychopharmacology2013
The effect of reboxetine co-administration with olanzapine on metabolic and endocrine profile in schizophrenia patients.
Avi Amrami-Weizman et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this paperpooled itcites it